Computer Supported Cooperative Work
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q3
Impact factor
2
SJR
0.798
CiteScore
6.4
Categories
Computer Science (miscellaneous)
Areas
Computer Science
Years of issue
1992-2025
journal names
Computer Supported Cooperative Work
Computer Supported Cooperative Work (CSCW)
COMPUT SUPP COOP W J
Top-3 citing journals

Computer Supported Cooperative Work
(2344 citations)

Proceedings of the ACM on Human-Computer Interaction
(1109 citations)

Lecture Notes in Computer Science
(1045 citations)
Top-3 organizations

University of Siegen
(48 publications)

Lancaster University
(43 publications)

Aarhus University
(28 publications)

University of Siegen
(19 publications)

University of Copenhagen
(11 publications)

Norwegian University of Science and Technology
(9 publications)
Top-3 countries
Most cited in 5 years
Found
Publications found: 7507
Q2

Cough-induced rectus sheath hematoma in a healthy adult male – a case report
Jaishi S., Chhetri S.K., Thapa S., Suraj K.C., Khanal B.
Introduction and importance:
Spontaneous rectus sheath hematoma (RSH) is a rare and underdiagnosed condition that can mimic more serious causes of acute abdominal pain leading to unnecessary surgery or delay in management. It occurs due to bleeding within the rectus sheath, often caused by the rupture of epigastric vessels or rectus abdominis muscle.
Case presentation:
In the case presented in this study, a 47-year-old man presented with acute left upper quadrant pain and a painful abdominal mass following a severe coughing episode. Imaging confirmed a rectus sheath hematoma. Conservative management, including bed rest and pain relief, led to recovery. At follow-up, the patient was asymptomatic and advised to quit smoking.
Discussion:
Spontaneous rectus sheath hematoma (RSH) is a rare cause of acute abdominal pain, often triggered by coughing, sneezing, or vomiting. Risk factors include hypertension, obesity, and anticoagulant use. This case highlights a RSH in the left upper quadrant, a less common site diagnosed through ultrasound and CT. While most cases are managed conservatively, surgical intervention is necessary in complicated cases.
Conclusion:
Rectus sheath hematoma, though uncommon, should be considered in patients presenting with acute abdominal pain and a history of intense coughing even in absence of abdominal trauma or anticoagulant therapy.
Q2

Epidemiology, clinic, therapeutic, and outcome of pelvic organ prolapse: a retrospective single-center cohort study
Amadou Issa A., Soumana Diaouga H., Lankonde Salifou Z., Abdoul-Wahab Mahamadou M., Oumara M., Oumarou Garba S., Harouna Salifou J., Abdoulaye M.B., Nouhou H., Nayama M.
Introduction:
Pelvic organ prolapse (POP) is a major public health problem. This study aims to determine the incidence, sociodemographic profile of patients, the management and outcomes of POP in a maternity hospital with limited resources in Niger.
Methodology:
This was an eight-year retrospective cohort study involving the analysis of medical records from patients who underwent management of POP between 1 January 2015 and 31 December 2022 in our department. The epidemiological data, treatment, and outcomes of POP were collated and subjected to analysis.
Results:
During the study period, 358 cases of POP were recorded out of a total of 12 536 patients treated in the department, representing a frequency of 2.8%. The mean age of the patients was 46.14 years (range: 17–90 years). The patients were identified as married (307 cases, 85.75%), unemployed (353 cases, 98.6%) and not attending school (332 cases, 92.74%). The largest number of cases were observed in large multiparous women (60.05%, 215 patients). The average parity was 6.5 children. The vast majority of patients (269 cases, 75.14%) lived in rural areas. The most frequent motif for consultation was the sensation of mass in the vagina (146 cases, 40.78%) and vulvar swelling (138 cases, 38.55%). The most frequent genital prolapses type was middle, made of the hysterocele essentially (150 cases, 41.90%). The stage III of genital prolapses was the most frequent in 76.51% (274 cases). All patients underwent surgical treatment (100%), and the vaginal access was most used in 57.55% (206 cases) of cases. Conservative treatment was performed in the majority of patients (197 cases, 55.02%). The intraoperative complications were vesical lesions (0.56%, two cases) and ureteral and vascular lesion (0.28%, one case).
Conclusion:
POP is a common occurrence in our region. Surgical treatment is the most practiced and hysterectomy by vaginal surgical approach is the most practiced.
Q2

Diabetes mellitus awareness among students attending a public high school in Kurdistan Region of Iraq: a cross-sectional study
Mosa A.A., Abdulqadir H.H., Khalid R.C., Mustafa A.A., Zaki H.A., Yousif I.R., Yaseen O.S., Dinkha S.E., Khamo H.M., Mohammad A.M.
Background and aim:
Diabetes mellitus (DM) is a chronic metabolic disorder and a significant global concern due to its steadily increasing prevalence. Educating youths and adolescents about such diseases is crucial for promoting healthy lifestyle choices. This study aims to evaluate the knowledge of public high school students about DM and identify areas where their understanding is lacking.
Materials and methodology:
In February 2023, a descriptive cross-sectional study was conducted in the Duhok province of the Kurdistan Region in Iraq. The study enrolled 392 students from a public high school, who were surveyed using a self-administered questionnaire. This questionnaire had two sections: the first collected basic demographic information of the participants, while the second included 20 items assessing various aspects of DM knowledge, such as general information, risk factors, signs and symptoms, complications, and prevention.
Results:
The mean age of the study participants was 16.4 years (±0.71). Among the participants, 247 (63%) were female, and 190 (48.5%) had a positive family history of DM. Unfortunately, only 53 students (13.5%) had received training programs about the disease, although the vast majority (89.3%) expressed willingness to participate in the prevention programs. For 70.2% of the participants, family and friends were the primary sources of information. The mean knowledge score was 13.9 (±3), with an average correct answer rate of 68.55%. Female students, those with a positive family history, had significantly demonstrated a better overall knowledge score with a mean knowledge score of 14.14 ± 2.96 and 14.17 ± 2.98, respectively. Also, participants using multiple sources for information, and those who had received training programs on DM, demonstrated a better overall knowledge score with a mean score of 14.21 ± 2.90 and 14.34 ± 3.31, respectively. However, it missed the significance.
Conclusion:
The study participants exhibited good knowledge and awareness of DM. However, there were notable gaps in their understanding of the disease’s risk factors and complications. Therefore, we recommend incorporating health education programs and lifestyle modification initiatives into the school curriculum to enhance students’ knowledge and address the identified gaps.
Q2

Clinical implications of apolipoprotein L1 testing in patients with focal segmental glomerulosclerosis: a review of diagnostic and prognostic implications
Waheed A., Gul M.H., Naeem R., Qayyum S.N., Batool K., Shaukat A., Khan N., Shah S.I., Siddiqui A.R., Farooq A.U., Nasir E., Noori S.
Introduction:
Focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome, contributing to 40% of adult and 20% of pediatric cases globally. Apolipoprotein L1 (APOL1) genetic variants, particularly G1 and G2 alleles, play a pivotal role in FSGS pathogenesis, particularly among African-Americans, where 30–40% carry these risk alleles. These variants impair APOL1 function, causing podocyte injury, proteinuria, and progressive kidney damage. Secondary triggers like infections exacerbate susceptibility. Advances in gene-editing technologies, including CRISPR, offer hope for targeted therapies in FSGS management.
Objectives:
This review explores the link between APOL1 variants and FSGS pathogenesis, focusing on their role in podocyte injury and assessing the utility of APOL1 genetic testing in diagnosis and treatment strategies.
Methodology:
A systematic literature review was conducted using Medline, PubMed, Google Scholar, and PsychINFO up to April 2024. Of 331 identified articles, 29 relevant studies were analyzed, emphasizing APOL1 variants’ role in FSGS and implications for genetic testing.
Results:
About 13% of African-Americans carry APOL1 risk alleles, with 30% having at least one allele. Two risk alleles increase lifetime FSGS risk to 4% and ESKD risk to 7–8%. APOL1-associated kidney damage primarily affects podocytes, accelerating glomerulosclerosis. Emerging treatments, such as inaxaplin, reduced proteinuria by 47%, with 40% achieving remission in FSGS cases linked to APOL1.
Q2

Association between Islamic religiosity and preoperative anxiety in liver and renal transplant patients: a single-centered study from Pakistan
Khattak U.K., Hameed M., Ahmer H., Sajid S., Khan Afridi S.
Introduction:
This study investigates the association between religiosity and preoperative anxiety in liver and renal transplant patients at a tertiary care hospital in Pakistan. This study aims to explore the association between Islamic religiosity and preoperative anxiety in liver and renal transplant patients at a tertiary care hospital in Islamabad.
Objectives:
It seeks to assess preoperative anxiety levels in both donors and recipients, examine the relationship between religiosity and preoperative anxiety, and investigate the role of religiosity as a coping mechanism in managing preoperative anxiety.
Methods:
Conducted on 140 patients over 2 years using non-probability convenience sampling and validated tools, significant associations were found between anxiety levels and gender, marital status, age, education, spouse occupation, and transplant type.
Results:
Older adults and liver transplant recipients reported higher anxiety. Significant correlations were found between transplant type and anxiety age differences in anxiety (F(3,136) = 4.5, P < 0.05) and anesthesia anxiety (F(3,136) = 6.6, P < 0.05). Liver transplant recipients reported higher anxiety than donors. Religious coping strategies, such as seeking Allah’s guidance, were linked to lower anxiety, particularly among liver transplant recipients.
Conclusion:
The study found that demographic factors such as age, gender, marital status, and transplant type significantly influence anxiety levels. Older adults and liver transplant recipients experienced higher levels of anxiety. Notably, religious coping strategies, including seeking Allah’s guidance, were associated with lower anxiety, especially among liver transplant recipients. The findings suggest that religiosity may serve as a valuable coping mechanism and highlight the need for further research on spiritual interventions in transplant care.
Q2

Bibliometric analysis of artificial intelligence applications in cardiovascular imaging: trends, impact, and emerging research areas
Alotaibi H., Contreas R., Thakker N., Mahapatro A., Adla Jala S.R., Mohanty E., Devulapally P., Mirchandani M., Marsool Marsool M.D., Jain S.M., Joukar F., Alizadeh Asl A., Hosseini Jebelli S.F., Amini-Salehi E., Ameen D.
Background:
The application of artificial intelligence (AI) in cardiac imaging has rapidly evolved, offering enhanced accuracy and efficiency in the diagnosis and management of cardiovascular diseases. This bibliometric study aimed to evaluate research trends, impact, and scholarly output in this expanding field.
Methods:
A systematic search was conducted on 14 August 2024, using the Web of Science Core Collection database. VOSviewer, CiteSpace, and Biblioshiny were utilized for data analysis.
Results:
The findings revealed a significant increase in publications on AI in cardiovascular imaging, particularly from 2018 to 2023, with the United States leading in research output. England and the United States have emerged as central hubs in the global research network, highlighting their role in generating high-quality and impactful publications. The University of London was identified as the top contributing institution, while Frontiers in Cardiovascular Medicine was the most prolific journal. Keyword analysis highlighted machine learning, echocardiography, and diagnosis as the most frequently occurring terms. A time trend analysis showed a shift in research focus towards AI applications in cardiac computed tomography (CT) and magnetic resonance imaging (MRI), with recent keywords like ejection fraction, risk, and heart failure reflecting emerging areas of interest.
Conclusion:
Healthcare providers should consider integrating AI tools into cardiovascular imaging practice, as AI has demonstrated the potential to enhance diagnostic accuracy and improve patient outcomes. This study highlights the rising importance of AI in personalized and predictive cardiovascular care, urging healthcare providers to stay informed about these advancements to enhance clinical decision-making and patient management.
Q2

Chemotherapy with a molecular rational basis, pentoxifylline as a promising antitumor drug
Cerda-Cruz C.R., Vazquez-Urrutia J.R., Ortiz-Lazareno P., Villaseñor-García M.M., Cruz-Lozano R., Hernandez-Flores G., Bravo-Cuellar A.
Cancer is one of the leading causes of death worldwide. In cancer therapy, anti-cancer drugs are the current treatment-of-choice for patients with metastatic cancers, but these drugs present a major drawback: they destroy healthy cells along with cancerous cells. Unfortunately, the drug discovery process for de novo drugs is costly and time-consuming. To address this global problem, our research team has established the concept of “Chemotherapy with a molecular rational basis”, which focuses on the identification of molecular targets in tumor cells, whose activation or inhibition induces apoptosis or sensitizes the tumor cells to apoptosis. Here we review the experimental and clinical evidence of pentoxifylline (PTX) in the setting of chemotherapy with a molecular rational basis. A search of the literature was conducted for articles published during the period from 2 January 2003 to 21 October 2024. Articles published in English or Spanish were included. The keywords “Pentoxifylline” OR “BL 191” OR “trental” AND “cancer” were used for in vitro, in vivo, and clinical studies. PTX is an approved, accessible, and relatively safe drug. Furthermore there is a large body of experimental and clinical evidence of the beneficial effects of PTX in cancer therapy, either alone or in combination with antitumor drugs, sometimes even more effective than traditional chemotherapy regimens. However, it is necessary to carry out larger clinical trials in cancer patients to identify the benefits, adverse effects and even pharmacological interactions of PTX with current chemotherapy regimens and thus achieve a new drug repositioning that benefits our patients.
Q2

Platelet activation in breast cancer: mechanisms and therapeutic opportunities – a narrative review
Obeagu E.I.
Platelet activation is increasingly recognized as a key factor in breast cancer progression, contributing to tumor growth, metastasis, and immune modulation. Platelets interact with tumor cells to promote their survival, facilitate metastasis, and enhance the formation of a pro-inflammatory microenvironment. These interactions are mediated by adhesion molecules such as P-selectin and glycoprotein receptors on both platelets and tumor cells. Additionally, activated platelets release growth factors like vascular endothelial growth factor and platelet-derived growth factor, which promote angiogenesis and tumor vascularization, crucial steps in cancer progression. The coagulation cascade, triggered by platelet activation, further enhances tumor cell dissemination and metastasis. Elevated levels of procoagulant activity in platelets, particularly through the expression of tissue factor, lead to increased thrombin generation, facilitating the formation of fibrin-rich clots that protect circulating tumor cells from immune surveillance. Platelet-derived factors also exert immunomodulatory effects, helping cancer cells evade detection by the immune system, thereby supporting tumor growth and spread.
Q2

Deep brain stimulation (DBS) in movement disorders management: exploring therapeutic efficacy, neurobiological mechanisms, and clinical implications
Hussein A.F., Imran W.M., Serag I., Abbas A., Mohamed Hammad E., Al-Aish S.T., Mahmoud D., Zazo Hassan A.M., Ghattas A.S., Megali M.H., Muthana A., Hashim Almusawi A.A., Chaurasia B.
Introduction:
Deep brain stimulation (DBS) has emerged as a promising therapeutic approach, offering targeted neuromodulation for movement disorders refractory to medical management or stereotactic surgery. However, assessing its benefits against potential risks is essential. This meta-analysis aims to evaluate the efficacy and safety of DBS in movement disorders, shedding light on its role as an alternative therapeutic option.
Methods:
A comprehensive search of databases after systemic review yielded studies published in English from 2000 to the present. Data selection, screening, extraction, and risk of bias assessment were performed meticulously. Statistical analysis was conducted using RevMan 2.0, with significant heterogeneity addressed through appropriate methods.
Results:
Our meta-analysis included 40 studies assessing the Unified Parkinson’s Disease Rating Scale Part III, revealing a significant improvement in motor symptoms (mean difference [MD]: −18.05, 95% confidence interval [CI] [−20.17, −15.93], P < 0.00001). Hoehn and Yahr Stage analysis demonstrated a reduction in disease severity (MD: −0.58, 95% CI [−1.05, −0.12], P = 0.01). Tremor severity (MD: −8.22, 95% CI [−12.30, −4.15], P < 0.0001), overall tremor (MD: −2.68, 95% CI [−4.59, −0.77], P = 0.006), gait velocity (MD: 0.13, 95% CI [0.08, 0.18], P < 0.00001), and Yale Global Tic Severity Scale score (MD: −9.75, 95% CI [−14.55, −4.96], P < 0.0001) also showed significant improvements with DBS.
Conclusion:
DBS demonstrates efficacy in improving motor symptoms, disease severity, tremor, gait, and tic severity in movement disorders. However, further research is needed to elucidate long-term efficacy and safety outcomes.
Q2

Directly acting antivirals improve insulin resistance in nondiabetic patients with hepatitis C: a systematic review and meta-analysis
Lamichhane P., Makhlouf S.S., Saleem K., Jitendrabhai Senjaliya D., Wajid A., Khanal K., Agrawal A.
Aims:
Insulin resistance, beta-cell dysfunction, and diabetes mellitus (DM) are the extrahepatic complications of chronic hepatitis C virus (HCV) infection. The aim of the study was to determine the effects of novel directly acting antivirals (DAAs) on insulin resistance and insulin sensitivity parameters in nondiabetic patients with chronic HCV infection.
Methods:
A systematic search of medical databases (Pubmed, Scopus, and Google Scholar) was conducted for studies published until July 2024. Studies investigating the effect of any DAA on insulin resistance and insulin sensitivity parameters in non-diabetic patients with chronic HCV and sustained virologic response were included. Our study assessed the Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) as the primary outcome. The pooled outcomes were compared pretreatment and posttreatment with DAAs using Hedges’ g (HG) with a 95% confidence interval (CI).
Results:
A total of 10 studies (1309 participants) were included in the meta-analysis. Insulin resistance measured by the HOMA-IR was significantly reduced with DAA therapy (HG = 0.86, 95% CI: 0.48–1.25, P < 0.001). A similar significant reduction in fasting insulin levels was observed following DAA therapy (HG = 0.88, 95% CI: 0.51–1.25, P < 0.001). However, no significant differences were seen in Homeostasis model assessment for beta-cell function (HOMA-B) (HG = 0.12, 95% CI: −0.0 to 0.24, P = 0.06) before and after DAAs use.
Conclusions:
The use of DAAs in nondiabetic chronic HCV patients with a sustained virologic response also significantly reduces insulin resistance and fasting insulin levels.
Q2

Assessing basic life support awareness, and knowledge among university undergraduates: a cross-sectional study
Baklola M., Elnemr M., Ghazy M., Omar Y., Darwish N.E., Ahmed B., Alkalla E., Reda R., Elmimy H., Mohamed T., Sherif A., Al-Bawah N., Shaheena D.G.
Background:
Basic life support (BLS) is a critical skill for saving lives during emergencies. This study aims to assess BLS awareness and knowledge among undergraduates at University, examining the impact of gender, faculty, and prior correct cardiopulmonary resuscitation (CPR) training on students’ confidence and competence.
Methods:
A descriptive, cross-sectional study was conducted from August to December 2023 across six faculties: medicine, nursing, engineering, sciences, commerce, and law. Using convenience sampling, a total of 1165 students participated by completing a self-administered, bilingual questionnaire. Descriptive statistics, Pearson correlation tests, t-tests, ANOVA, and multivariate logistic regression analyses were performed using SPSS software version 26, with visual representations created using R software.
Results:
The majority of participants were female (64.8%), with a significant portion (70%) believing that CPR training should be mandatory. Only 29.6% had received CPR training. Females scored higher on BLS knowledge than males (4.9 vs. 4.5, P < 0.05). Students from medical faculties had greater BLS knowledge compared to their non-medical peers (6.3 vs. 3.5, P < 0.05). Trained students were more confident in performing CPR (35.1% vs. 10.2% among untrained, P < 0.05). Multivariate logistic regression identified prior CPR training and medical faculty enrollment as significant predictors of higher BLS knowledge and confidence.
Conclusion:
Significant gaps in BLS knowledge and training exist among University undergraduates, with disparities based on gender, faculty, and prior training. The findings underscore the need for mandatory CPR training across all faculties to enhance student preparedness and competence.
Q2

Primary hydatid cyst in rectus abdominis muscle: a rare presentation on an unusual location
Acharya R., Saud G.S., Bista B., Mishra B., Yadav S.D., Mahato S.K.
Introduction:
Hydatid disease, caused by Echinococcus granulosus, commonly affects the liver (80%) and lungs (15%). Muscular involvement is rare, with primary hydatid cysts in skeletal muscles comprising only 2–3% of cases. This report presents the first documented case of a primary hydatid cyst in the rectus abdominis muscle in Nepal, and the 11th case globally.
Case presentation:
A 38-year-old female presented with a progressively enlarging epigastric swelling and localized pain over 1 year. On examination, a firm, non-tender 5 × 5 cm mass was palpated in the left rectus abdominis muscle. Imaging, including ultrasonography and contrast-enhanced CT, showed a well-defined cystic lesion without involvement of other organs. Serology for hydatid disease was negative. The cyst was excised surgically under general anesthesia, ensuring no spillage, and the surgical site was irrigated with hypertonic saline. Histopathology revealed acellular laminated keratin, protoscolices, and inflammatory infiltrates. Postoperatively, the patient received albendazole for 4 weeks and recovered uneventfully, with no recurrence on follow-up.
Discussion:
Primary muscular hydatid cysts are rare, as muscle contraction and lactic acid provide an unfavorable environment for the parasite. Imaging plays a vital role, as serology often yields false negatives. Surgical excision is the gold standard treatment, supported by anthelmintic therapy to prevent recurrence.
Conclusion:
This case highlights a rare presentation of hydatid disease in the rectus abdominis muscle, underscoring the importance of considering atypical locations in diagnosis. Early surgical intervention and postoperative medical therapy ensure positive outcomes.
Q2

A rare case of symmetric quadriplegia in a patient with japanese encephalitis: a case report
Basnet P., Singh P.R., Pudasaini K.R., Shrestha S., Kc A.
Introduction and importance:
Acute flaccid paralysis is a rare neurological complication of Japanese Encephalitis infection, which may involve one or multiple limbs. Symmetric involvement of upper and lower limbs such as in this case is rarely reported.
Presentation of case:
We present a case of a 30-year young male from terai region of Nepal who presented with fever, altered level of consciousness, and symmetrical quadriplegia. Based on these clinical findings, cerebrospinal fluid (CSF) analysis was done which came back negative. And based on results, Polymerase Chain Reaction (PCR) for herpes simplex virus (HSV) type I and II was done which came out negatively. Other neurological conditions such as Amyotrophic Lateral Sclerosis (ALS) and spinal dystrophy were ruled out because of the presence of fever and altered mental status. He was eventually diagnosed with Japanese encephalitis based on his cerebrospinal fluid analysis and positive result for JE serology/IgM Antibody Capture Enzyme-Linked Immunosorbent Assay (MAC-ELISA) test.
Clinical discussion:
The patient presented with fever, altered mental status and symmetrical flaccid paralysis of the bilateral upper and lower limb. Symmetrical involvement of the upper and the lower limbs is unusual in most cases of Japanese Encephalitis.
Conclusion:
This case highlights the importance of awareness on the part of the clinician about the possibilities of atypical presentation in Japanese encephalitis (JE). It also emphasizes that Japanese encephalitis should be a part of the differential in patients with atypical neurological presentation in endemic areas.
Q2

A multidisciplinary review of long COVID to address the challenges in diagnosis and updated management guidelines
Abbas A.H., Haji M.R., Shimal A.A., Kurmasha Y.H., Al-Janabi A.A., Azeez Z.T., Al-Ali A.R., Al-Najati H.M., Al-Waeli A.R., Abdulhadi N.A., Al-Tuaama A.Z., Al-Ashtary M.M., Hussin O.A.
Long COVID has emerged as a significant challenge since the COVID-19 pandemic, which was declared as an outbreak in March 2020, marked by diverse symptoms and prolonged duration of disease. Defined by the WHO as symptoms persisting or emerging for at least two months post-SARS-CoV-2 infection without an alternative cause, its prevalence varies globally, with estimates of 10–20% in Europe, 7.3% in the USA, and 3.0% in the UK. The condition’s etiology remains unclear, involving factors, such as renin–angiotensin system overactivation, persistent viral reservoirs, immune dysregulation, and autoantibodies. Reactivated viruses, like EBV and HSV-6, alongside epigenetic alterations, exacerbate mitochondrial dysfunction and energy imbalance. Emerging evidence links SARS-CoV-2 to chromatin and gut microbiome changes, further influencing long-term health impacts. Diagnosis of long COVID requires detailed systemic evaluation through medical history and physical examination. Management is highly individualized, focusing mainly on the patient’s symptoms and affected systems. A multidisciplinary approach is essential, integrating diverse perspectives to address systemic manifestations, underlying mechanisms, and therapeutic strategies. Enhanced understanding of long COVID’s pathophysiology and clinical features is critical to improving patient outcomes and quality of life. With a growing number of cases expected globally, advancing research and disseminating knowledge on long COVID remain vital for developing effective diagnostic and management frameworks, ultimately supporting better care for affected individuals.
Q2

A new chapter in CML treatment: the promise of asciminib
Akhtar M., Jamal Z., Mughal S., Mahmmoud Fadelallah Eljack M.
Asciminib, a groundbreaking treatment for chronic myeloid leukemia (CML), has gained FDA approval as the first STAMP inhibitor. Targeting the myristoyl pocket of the BCR-ABL1 protein, this drug offers a unique mechanism to overcome resistance to traditional tyrosine kinase inhibitors (TKIs). Clinical trials, such as the ASC4FIRST study, demonstrate asciminib’s superior efficacy compared to existing TKIs, achieving higher molecular response rates and fewer severe side effects. Its favorable safety profile, characterized by reduced vascular and pulmonary risks, supports improved patient adherence and long-term outcomes. While asciminib shows promise as a second-line or even frontline therapy, long-term data on its durability, adverse effects, and potential drug interactions are still evolving. Current research highlights its potential use in pediatric cases and in combination therapies for other leukemia types. Asciminib represents a significant advancement in CML treatment, paving the way for more targeted and tolerable cancer therapies.
Top-100
Citing journals
500
1000
1500
2000
2500
|
|
Computer Supported Cooperative Work
2344 citations, 8.62%
|
|
Proceedings of the ACM on Human-Computer Interaction
1109 citations, 4.08%
|
|
Lecture Notes in Computer Science
1045 citations, 3.84%
|
|
ACM Transactions on Computer-Human Interaction
239 citations, 0.88%
|
|
International Journal of Human Computer Studies
184 citations, 0.68%
|
|
International Journal of Medical Informatics
160 citations, 0.59%
|
|
SSRN Electronic Journal
143 citations, 0.53%
|
|
Interacting with Computers
127 citations, 0.47%
|
|
International Journal of Human-Computer Interaction
122 citations, 0.45%
|
|
Behaviour and Information Technology
114 citations, 0.42%
|
|
Human-Computer Interaction
109 citations, 0.4%
|
|
Pen-and-Paper User Interfaces
104 citations, 0.38%
|
|
Computers in Human Behavior
98 citations, 0.36%
|
|
IFIP Advances in Information and Communication Technology
97 citations, 0.36%
|
|
Cognition, Technology and Work
93 citations, 0.34%
|
|
Lecture Notes in Business Information Processing
91 citations, 0.33%
|
|
Journal of Information Technology
85 citations, 0.31%
|
|
Personal and Ubiquitous Computing
85 citations, 0.31%
|
|
Journal of the Association for Information Science and Technology
84 citations, 0.31%
|
|
Communications in Computer and Information Science
83 citations, 0.31%
|
|
Information and Software Technology
77 citations, 0.28%
|
|
CoDesign
74 citations, 0.27%
|
|
Health Informatics Journal
73 citations, 0.27%
|
|
Advances in Intelligent Systems and Computing
66 citations, 0.24%
|
|
European Journal of Information Systems
65 citations, 0.24%
|
|
Journal of Systems and Software
61 citations, 0.22%
|
|
Sustainability
59 citations, 0.22%
|
|
IEEE Transactions on Visualization and Computer Graphics
59 citations, 0.22%
|
|
IEEE Transactions on Software Engineering
58 citations, 0.21%
|
|
Science Technology and Human Values
58 citations, 0.21%
|
|
IEEE Access
57 citations, 0.21%
|
|
Information Systems Journal
55 citations, 0.2%
|
|
New Media and Society
55 citations, 0.2%
|
|
Proceedings of the Human Factors and Ergonomics Society
53 citations, 0.19%
|
|
Design Studies
52 citations, 0.19%
|
|
Journal of Documentation
51 citations, 0.19%
|
|
Proceedings of the Association for Information Science and Technology
51 citations, 0.19%
|
|
International Journal of Computer-Supported Collaborative Learning
50 citations, 0.18%
|
|
International Journal of Cooperative Information Systems
48 citations, 0.18%
|
|
Information and Organization
47 citations, 0.17%
|
|
AI and Society
46 citations, 0.17%
|
|
Social Science and Medicine
45 citations, 0.17%
|
|
Journal of the American Society for Information Science and Technology
45 citations, 0.17%
|
|
Information Technology and People
44 citations, 0.16%
|
|
i-com
43 citations, 0.16%
|
|
Information Systems Research
43 citations, 0.16%
|
|
Journal of Computer-Mediated Communication
40 citations, 0.15%
|
|
Journal of Medical Internet Research
38 citations, 0.14%
|
|
Procedia Computer Science
37 citations, 0.14%
|
|
PLoS ONE
37 citations, 0.14%
|
|
Journal of Pragmatics
36 citations, 0.13%
|
|
International Journal of Information Management
35 citations, 0.13%
|
|
Social Studies of Science
35 citations, 0.13%
|
|
Revue d'Anthropologie des Connaissances
33 citations, 0.12%
|
|
New Technology, Work and Employment
32 citations, 0.12%
|
|
Computers and Education
32 citations, 0.12%
|
|
Annual Review of Information Science and Technology
31 citations, 0.11%
|
|
International Journal of Environmental Research and Public Health
30 citations, 0.11%
|
|
Virtual Reality
30 citations, 0.11%
|
|
International Journal of Disaster Risk Reduction
30 citations, 0.11%
|
|
International Journal of e-Collaboration
29 citations, 0.11%
|
|
Information Systems Frontiers
29 citations, 0.11%
|
|
Empirical Software Engineering
29 citations, 0.11%
|
|
Information Society
29 citations, 0.11%
|
|
Lecture Notes in Information Systems and Organisation
28 citations, 0.1%
|
|
Business and Information Systems Engineering
28 citations, 0.1%
|
|
Cultures in Human-Computer Interaction
28 citations, 0.1%
|
|
Expert Systems with Applications
27 citations, 0.1%
|
|
Organization Science
27 citations, 0.1%
|
|
Proceedings of the American Society for Information Science and Technology
27 citations, 0.1%
|
|
Frontiers in Psychology
26 citations, 0.1%
|
|
Games and Culture
26 citations, 0.1%
|
|
Mind, Culture, and Activity
25 citations, 0.09%
|
|
Applied Sciences (Switzerland)
25 citations, 0.09%
|
|
Lecture Notes in Networks and Systems
25 citations, 0.09%
|
|
Journal of Biomedical Informatics
24 citations, 0.09%
|
|
Journal of the American Medical Informatics Association : JAMIA
24 citations, 0.09%
|
|
Education and Information Technologies
23 citations, 0.08%
|
|
Information Communication and Society
23 citations, 0.08%
|
|
Journal of Workplace Learning
23 citations, 0.08%
|
|
Educational Technology Research and Development
23 citations, 0.08%
|
|
Big Data and Society
22 citations, 0.08%
|
|
Information Processing and Management
22 citations, 0.08%
|
|
Information and Management
22 citations, 0.08%
|
|
Group Decision and Negotiation
22 citations, 0.08%
|
|
Journal of Ambient Intelligence and Humanized Computing
21 citations, 0.08%
|
|
British Journal of Educational Technology
21 citations, 0.08%
|
|
Sociology of Health and Illness
21 citations, 0.08%
|
|
IEEE Transactions on Professional Communication
21 citations, 0.08%
|
|
Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies
21 citations, 0.08%
|
|
Safety Science
20 citations, 0.07%
|
|
Artificial Intelligence for Engineering Design, Analysis and Manufacturing: AIEDAM
20 citations, 0.07%
|
|
Sociologie du Travail
20 citations, 0.07%
|
|
Universal Access in the Information Society
20 citations, 0.07%
|
|
Lecture Notes of the Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering
19 citations, 0.07%
|
|
International Journal of Sociotechnology and Knowledge Development
19 citations, 0.07%
|
|
Communications of the ACM
19 citations, 0.07%
|
|
Decision Support Systems
19 citations, 0.07%
|
|
Design Journal
19 citations, 0.07%
|
|
Activites
19 citations, 0.07%
|
|
Show all (70 more) | |
500
1000
1500
2000
2500
|
Citing publishers
1000
2000
3000
4000
5000
6000
7000
|
|
Springer Nature
6082 citations, 22.37%
|
|
Association for Computing Machinery (ACM)
4815 citations, 17.71%
|
|
Elsevier
2227 citations, 8.19%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1885 citations, 6.93%
|
|
Taylor & Francis
1848 citations, 6.8%
|
|
SAGE
1176 citations, 4.33%
|
|
Wiley
1175 citations, 4.32%
|
|
IGI Global
784 citations, 2.88%
|
|
Emerald
640 citations, 2.35%
|
|
MDPI
281 citations, 1.03%
|
|
Oxford University Press
237 citations, 0.87%
|
|
Frontiers Media S.A.
161 citations, 0.59%
|
|
Cambridge University Press
150 citations, 0.55%
|
|
Social Science Electronic Publishing
147 citations, 0.54%
|
|
JMIR Publications
129 citations, 0.47%
|
|
Walter de Gruyter
102 citations, 0.38%
|
|
OpenEdition
102 citations, 0.38%
|
|
Institute for Operations Research and the Management Sciences (INFORMS)
80 citations, 0.29%
|
|
World Scientific
79 citations, 0.29%
|
|
CAIRN
75 citations, 0.28%
|
|
John Benjamins Publishing Company
48 citations, 0.18%
|
|
Public Library of Science (PLoS)
43 citations, 0.16%
|
|
Hindawi Limited
33 citations, 0.12%
|
|
BMJ
32 citations, 0.12%
|
|
Academy of Management
31 citations, 0.11%
|
|
Mary Ann Liebert
29 citations, 0.11%
|
|
Georg Thieme Verlag KG
26 citations, 0.1%
|
|
IOS Press
25 citations, 0.09%
|
|
Ovid Technologies (Wolters Kluwer Health)
19 citations, 0.07%
|
|
ASME International
17 citations, 0.06%
|
|
MIT Press
16 citations, 0.06%
|
|
American Society of Civil Engineers (ASCE)
16 citations, 0.06%
|
|
Scandinavian University Press / Universitetsforlaget AS
15 citations, 0.06%
|
|
Intellect
15 citations, 0.06%
|
|
University of Chicago Press
13 citations, 0.05%
|
|
Ubiquity Press
13 citations, 0.05%
|
|
Consortium Erudit
13 citations, 0.05%
|
|
F1000 Research
13 citations, 0.05%
|
|
IOP Publishing
12 citations, 0.04%
|
|
National Institute for Health and Care Research (NIHR)
12 citations, 0.04%
|
|
EDP Sciences
11 citations, 0.04%
|
|
Annual Reviews
11 citations, 0.04%
|
|
Trans Tech Publications
10 citations, 0.04%
|
|
The Royal Society
10 citations, 0.04%
|
|
Morgan & Claypool Publishers
10 citations, 0.04%
|
|
PeerJ
10 citations, 0.04%
|
|
SciELO
9 citations, 0.03%
|
|
Open Science Center, University of Jyvaskyla
8 citations, 0.03%
|
|
Cold Spring Harbor Laboratory
8 citations, 0.03%
|
|
American Educational Research Association
8 citations, 0.03%
|
|
Hogrefe Publishing Group
8 citations, 0.03%
|
|
American Institute of Mathematical Sciences (AIMS)
7 citations, 0.03%
|
|
7 citations, 0.03%
|
|
American Institute of Aeronautics and Astronautics (AIAA)
6 citations, 0.02%
|
|
International Medical Informatics Association
6 citations, 0.02%
|
|
American Psychological Association (APA)
6 citations, 0.02%
|
|
Scientific Research Publishing
6 citations, 0.02%
|
|
Bristol University Press
6 citations, 0.02%
|
|
Institution of Engineering and Technology (IET)
5 citations, 0.02%
|
|
IAE School of Management Montpellier University
5 citations, 0.02%
|
|
Canadian Science Publishing
5 citations, 0.02%
|
|
Inderscience Publishers
5 citations, 0.02%
|
|
University of Toronto Press Inc. (UTPress)
5 citations, 0.02%
|
|
AOSIS
5 citations, 0.02%
|
|
Tech Science Press
5 citations, 0.02%
|
|
Hans Publishers
5 citations, 0.02%
|
|
Human Factors and Ergonomics Society
5 citations, 0.02%
|
|
4 citations, 0.01%
|
|
AIP Publishing
4 citations, 0.01%
|
|
American Academy of Pediatrics
4 citations, 0.01%
|
|
4 citations, 0.01%
|
|
Society of Petroleum Engineers
4 citations, 0.01%
|
|
SPIE-Intl Soc Optical Eng
4 citations, 0.01%
|
|
IntechOpen
4 citations, 0.01%
|
|
Editora Edgard Blucher, Ltda.
4 citations, 0.01%
|
|
University of California Press
3 citations, 0.01%
|
|
Brill
3 citations, 0.01%
|
|
American Accounting Association
3 citations, 0.01%
|
|
Institute of Image Information and Television Engineers
3 citations, 0.01%
|
|
American Meteorological Society
3 citations, 0.01%
|
|
Fuji Technology Press
3 citations, 0.01%
|
|
Cornell University Press
3 citations, 0.01%
|
|
3 citations, 0.01%
|
|
National Coordinating Centre for Health Technology Assessment
3 citations, 0.01%
|
|
Engineering Project Organization Society
3 citations, 0.01%
|
|
Equinox Publishing
3 citations, 0.01%
|
|
Institut de recherche Robert-Sauvé en santé et en sécurité du travail
3 citations, 0.01%
|
|
Bentham Science Publishers Ltd.
2 citations, 0.01%
|
|
Edinburgh University Press
2 citations, 0.01%
|
|
Royal Society of Chemistry (RSC)
2 citations, 0.01%
|
|
Ediciones Universidad de Salamanca
2 citations, 0.01%
|
|
2 citations, 0.01%
|
|
Institut National de Recherche Pedagogique
2 citations, 0.01%
|
|
2 citations, 0.01%
|
|
electronic proceedings in theoretical computer science, eptcs
2 citations, 0.01%
|
|
Johann Ambrosius Barth
2 citations, 0.01%
|
|
Information Processing Society of Japan
2 citations, 0.01%
|
|
Goteborg University
2 citations, 0.01%
|
|
2 citations, 0.01%
|
|
American Association for Cancer Research (AACR)
2 citations, 0.01%
|
|
Show all (70 more) | |
1000
2000
3000
4000
5000
6000
7000
|
Publishing organizations
5
10
15
20
25
30
35
40
45
50
|
|
University of Siegen
48 publications, 3.42%
|
|
Lancaster University
43 publications, 3.06%
|
|
Aarhus University
28 publications, 1.99%
|
|
University of Oslo
28 publications, 1.99%
|
|
University of California, Irvine
28 publications, 1.99%
|
|
IT University of Copenhagen
25 publications, 1.78%
|
|
University of Copenhagen
25 publications, 1.78%
|
|
Copenhagen Business School
24 publications, 1.71%
|
|
University of Washington
21 publications, 1.5%
|
|
Vienna University of Technology
20 publications, 1.42%
|
|
Norwegian University of Science and Technology
19 publications, 1.35%
|
|
Pennsylvania State University
19 publications, 1.35%
|
|
Delft University of Technology
18 publications, 1.28%
|
|
University of Surrey
18 publications, 1.28%
|
|
University of Edinburgh
17 publications, 1.21%
|
|
University of Nottingham
17 publications, 1.21%
|
|
University of Illinois Urbana-Champaign
17 publications, 1.21%
|
|
University of Oulu
15 publications, 1.07%
|
|
Aalto University
14 publications, 1%
|
|
University of Michigan
13 publications, 0.93%
|
|
Stockholm University
12 publications, 0.85%
|
|
University of Manchester
12 publications, 0.85%
|
|
University of Gothenburg
11 publications, 0.78%
|
|
University of Milano-Bicocca
11 publications, 0.78%
|
|
University of Oxford
11 publications, 0.78%
|
|
Roskilde University
11 publications, 0.78%
|
|
Virginia Tech
11 publications, 0.78%
|
|
University College London
10 publications, 0.71%
|
|
King's College London
10 publications, 0.71%
|
|
Manchester Metropolitan University
10 publications, 0.71%
|
|
Carnegie Mellon University
10 publications, 0.71%
|
|
University of Sydney
10 publications, 0.71%
|
|
Stanford University
10 publications, 0.71%
|
|
Indiana University Bloomington
10 publications, 0.71%
|
|
Tampere University
9 publications, 0.64%
|
|
University of Helsinki
9 publications, 0.64%
|
|
University of Glasgow
9 publications, 0.64%
|
|
Georgia Institute of technology
9 publications, 0.64%
|
|
University of Sussex
9 publications, 0.64%
|
|
University of Jyväskylä
8 publications, 0.57%
|
|
UiT The Arctic University of Norway
8 publications, 0.57%
|
|
Syracuse University
8 publications, 0.57%
|
|
University of California, San Diego
8 publications, 0.57%
|
|
University of Calgary
8 publications, 0.57%
|
|
University of Colorado Boulder
7 publications, 0.5%
|
|
Aalborg University
6 publications, 0.43%
|
|
Technical University of Denmark
6 publications, 0.43%
|
|
Massachusetts Institute of Technology
6 publications, 0.43%
|
|
University of Melbourne
6 publications, 0.43%
|
|
University of Wollongong
6 publications, 0.43%
|
|
Newcastle University
6 publications, 0.43%
|
|
Ruhr University Bochum
6 publications, 0.43%
|
|
Simon Fraser University
6 publications, 0.43%
|
|
University of British Columbia
6 publications, 0.43%
|
|
University of Sheffield
6 publications, 0.43%
|
|
University of North Carolina at Chapel Hill
6 publications, 0.43%
|
|
KTH Royal Institute of Technology
5 publications, 0.36%
|
|
ETH Zurich
5 publications, 0.36%
|
|
University of Zurich
5 publications, 0.36%
|
|
Södertörn University
5 publications, 0.36%
|
|
University of Technology Sydney
5 publications, 0.36%
|
|
Queen Mary University of London
5 publications, 0.36%
|
|
University of Cambridge
5 publications, 0.36%
|
|
Queensland University of Technology
5 publications, 0.36%
|
|
University of Queensland
5 publications, 0.36%
|
|
City University of Hong Kong
5 publications, 0.36%
|
|
University of California, Berkeley
5 publications, 0.36%
|
|
Fraunhofer Institute for Applied Information Technology
5 publications, 0.36%
|
|
Bauhaus University Weimar
5 publications, 0.36%
|
|
Sheffield Hallam University
5 publications, 0.36%
|
|
University of Victoria
5 publications, 0.36%
|
|
University of Toronto
5 publications, 0.36%
|
|
University of Saskatchewan
5 publications, 0.36%
|
|
Texas A&M University
5 publications, 0.36%
|
|
Technical University of Munich
4 publications, 0.28%
|
|
Eindhoven University of Technology
4 publications, 0.28%
|
|
University of Turin
4 publications, 0.28%
|
|
Brunel University London
4 publications, 0.28%
|
|
Michigan State University
4 publications, 0.28%
|
|
University of Agder
4 publications, 0.28%
|
|
University of California, Santa Cruz
4 publications, 0.28%
|
|
New Jersey Institute of Technology
4 publications, 0.28%
|
|
Vrije Universiteit Amsterdam
4 publications, 0.28%
|
|
University of St Andrews
4 publications, 0.28%
|
|
University of Maryland, Baltimore County
4 publications, 0.28%
|
|
Erasmus University Rotterdam
4 publications, 0.28%
|
|
University College Cork (National University of Ireland, Cork)
4 publications, 0.28%
|
|
Malmö University
3 publications, 0.21%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
3 publications, 0.21%
|
|
Imperial College London
3 publications, 0.21%
|
|
University of Warwick
3 publications, 0.21%
|
|
Drexel University
3 publications, 0.21%
|
|
Cornell University
3 publications, 0.21%
|
|
Galeazzi Orthopaedic Institute
3 publications, 0.21%
|
|
Victoria University of Wellington
3 publications, 0.21%
|
|
University of Canterbury
3 publications, 0.21%
|
|
Commonwealth Scientific and Industrial Research Organization
3 publications, 0.21%
|
|
Reykjavik University
3 publications, 0.21%
|
|
New York University
3 publications, 0.21%
|
|
Ohio State University
3 publications, 0.21%
|
|
Show all (70 more) | |
5
10
15
20
25
30
35
40
45
50
|
Publishing organizations in 5 years
2
4
6
8
10
12
14
16
18
20
|
|
University of Siegen
19 publications, 13.87%
|
|
University of Copenhagen
11 publications, 8.03%
|
|
Norwegian University of Science and Technology
9 publications, 6.57%
|
|
Stockholm University
7 publications, 5.11%
|
|
Aarhus University
5 publications, 3.65%
|
|
University of Oslo
5 publications, 3.65%
|
|
University of Washington
5 publications, 3.65%
|
|
University of Helsinki
4 publications, 2.92%
|
|
University of Gothenburg
4 publications, 2.92%
|
|
Södertörn University
4 publications, 2.92%
|
|
Roskilde University
4 publications, 2.92%
|
|
Pennsylvania State University
4 publications, 2.92%
|
|
Lancaster University
4 publications, 2.92%
|
|
Tampere University
3 publications, 2.19%
|
|
University of Oulu
3 publications, 2.19%
|
|
Copenhagen Business School
3 publications, 2.19%
|
|
Carnegie Mellon University
3 publications, 2.19%
|
|
Newcastle University
3 publications, 2.19%
|
|
Vienna University of Technology
3 publications, 2.19%
|
|
Hochschule Bonn-Rhein-Sieg University of Applied Sciences
3 publications, 2.19%
|
|
Indiana University Bloomington
3 publications, 2.19%
|
|
University College Cork (National University of Ireland, Cork)
3 publications, 2.19%
|
|
Linnaeus University
2 publications, 1.46%
|
|
Aalto University
2 publications, 1.46%
|
|
Delft University of Technology
2 publications, 1.46%
|
|
UiT The Arctic University of Norway
2 publications, 1.46%
|
|
Technical University of Denmark
2 publications, 1.46%
|
|
King's College London
2 publications, 1.46%
|
|
University of Nottingham
2 publications, 1.46%
|
|
Lawrence Berkeley National Laboratory
2 publications, 1.46%
|
|
Free University of Bozen-Bolzano
2 publications, 1.46%
|
|
Victoria University of Wellington
2 publications, 1.46%
|
|
Reykjavik University
2 publications, 1.46%
|
|
Korea Advanced Institute of Science and Technology
2 publications, 1.46%
|
|
University of California, Berkeley
2 publications, 1.46%
|
|
University of California, Santa Cruz
2 publications, 1.46%
|
|
Vrije Universiteit Amsterdam
2 publications, 1.46%
|
|
University of Michigan
2 publications, 1.46%
|
|
University of British Columbia
2 publications, 1.46%
|
|
Technical University of Darmstadt
2 publications, 1.46%
|
|
University of Sussex
2 publications, 1.46%
|
|
University of Colorado Boulder
2 publications, 1.46%
|
|
Koc University
1 publication, 0.73%
|
|
University of Jeddah
1 publication, 0.73%
|
|
Imam Abdulrahman Bin Faisal University
1 publication, 0.73%
|
|
Peking University
1 publication, 0.73%
|
|
Katholieke Universiteit Leuven
1 publication, 0.73%
|
|
University of Twente
1 publication, 0.73%
|
|
Uppsala University
1 publication, 0.73%
|
|
University of Strasbourg
1 publication, 0.73%
|
|
KTH Royal Institute of Technology
1 publication, 0.73%
|
|
Linköping University
1 publication, 0.73%
|
|
ETH Zurich
1 publication, 0.73%
|
|
Malmö University
1 publication, 0.73%
|
|
Sapienza University of Rome
1 publication, 0.73%
|
|
University of Zurich
1 publication, 0.73%
|
|
University West
1 publication, 0.73%
|
|
Eindhoven University of Technology
1 publication, 0.73%
|
|
Polytechnic University of Milan
1 publication, 0.73%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
1 publication, 0.73%
|
|
University of Milano-Bicocca
1 publication, 0.73%
|
|
American University of Beirut
1 publication, 0.73%
|
|
University College London
1 publication, 0.73%
|
|
Durham University
1 publication, 0.73%
|
|
Queen Mary University of London
1 publication, 0.73%
|
|
Brunel University London
1 publication, 0.73%
|
|
University of Warwick
1 publication, 0.73%
|
|
University of Oxford
1 publication, 0.73%
|
|
University of Cambridge
1 publication, 0.73%
|
|
IT University of Copenhagen
1 publication, 0.73%
|
|
University of Verona
1 publication, 0.73%
|
|
University of Edinburgh
1 publication, 0.73%
|
|
Massachusetts Institute of Technology
1 publication, 0.73%
|
|
Michigan State University
1 publication, 0.73%
|
|
Loughborough University
1 publication, 0.73%
|
|
Galeazzi Orthopaedic Institute
1 publication, 0.73%
|
|
University of Udine
1 publication, 0.73%
|
|
Luxembourg Institute of Science and Technology
1 publication, 0.73%
|
|
University of Canterbury
1 publication, 0.73%
|
|
Monash University
1 publication, 0.73%
|
|
Stanford University
1 publication, 0.73%
|
|
Ebonyi State University
1 publication, 0.73%
|
|
Chinese University of Hong Kong
1 publication, 0.73%
|
|
City University of Hong Kong
1 publication, 0.73%
|
|
Clemson University
1 publication, 0.73%
|
|
Northwestern University
1 publication, 0.73%
|
|
Syracuse University
1 publication, 0.73%
|
|
Technical University of Berlin
1 publication, 0.73%
|
|
University of California, Santa Barbara
1 publication, 0.73%
|
|
New Jersey Institute of Technology
1 publication, 0.73%
|
|
Kyoto University
1 publication, 0.73%
|
|
University of Notre Dame
1 publication, 0.73%
|
|
University of Central Florida
1 publication, 0.73%
|
|
University of Luxembourg
1 publication, 0.73%
|
|
University of Crete
1 publication, 0.73%
|
|
Hasselt University
1 publication, 0.73%
|
|
University of Cologne
1 publication, 0.73%
|
|
Paris Cité University
1 publication, 0.73%
|
|
University of Macau
1 publication, 0.73%
|
|
Ruhr University Bochum
1 publication, 0.73%
|
|
Show all (70 more) | |
2
4
6
8
10
12
14
16
18
20
|
Publishing countries
50
100
150
200
250
300
350
|
|
USA
|
USA, 326, 23.22%
USA
326 publications, 23.22%
|
United Kingdom
|
United Kingdom, 223, 15.88%
United Kingdom
223 publications, 15.88%
|
Denmark
|
Denmark, 133, 9.47%
Denmark
133 publications, 9.47%
|
Germany
|
Germany, 116, 8.26%
Germany
116 publications, 8.26%
|
Norway
|
Norway, 73, 5.2%
Norway
73 publications, 5.2%
|
Sweden
|
Sweden, 67, 4.77%
Sweden
67 publications, 4.77%
|
Australia
|
Australia, 58, 4.13%
Australia
58 publications, 4.13%
|
Finland
|
Finland, 52, 3.7%
Finland
52 publications, 3.7%
|
France
|
France, 44, 3.13%
France
44 publications, 3.13%
|
Canada
|
Canada, 42, 2.99%
Canada
42 publications, 2.99%
|
Netherlands
|
Netherlands, 41, 2.92%
Netherlands
41 publications, 2.92%
|
Austria
|
Austria, 34, 2.42%
Austria
34 publications, 2.42%
|
Italy
|
Italy, 34, 2.42%
Italy
34 publications, 2.42%
|
Ireland
|
Ireland, 14, 1%
Ireland
14 publications, 1%
|
Switzerland
|
Switzerland, 13, 0.93%
Switzerland
13 publications, 0.93%
|
China
|
China, 11, 0.78%
China
11 publications, 0.78%
|
Brazil
|
Brazil, 10, 0.71%
Brazil
10 publications, 0.71%
|
Japan
|
Japan, 8, 0.57%
Japan
8 publications, 0.57%
|
New Zealand
|
New Zealand, 7, 0.5%
New Zealand
7 publications, 0.5%
|
Portugal
|
Portugal, 4, 0.28%
Portugal
4 publications, 0.28%
|
Greece
|
Greece, 4, 0.28%
Greece
4 publications, 0.28%
|
India
|
India, 4, 0.28%
India
4 publications, 0.28%
|
Republic of Korea
|
Republic of Korea, 4, 0.28%
Republic of Korea
4 publications, 0.28%
|
Belgium
|
Belgium, 3, 0.21%
Belgium
3 publications, 0.21%
|
Iceland
|
Iceland, 3, 0.21%
Iceland
3 publications, 0.21%
|
Saudi Arabia
|
Saudi Arabia, 3, 0.21%
Saudi Arabia
3 publications, 0.21%
|
Spain
|
Spain, 2, 0.14%
Spain
2 publications, 0.14%
|
Colombia
|
Colombia, 2, 0.14%
Colombia
2 publications, 0.14%
|
Nigeria
|
Nigeria, 2, 0.14%
Nigeria
2 publications, 0.14%
|
Turkey
|
Turkey, 2, 0.14%
Turkey
2 publications, 0.14%
|
Chile
|
Chile, 2, 0.14%
Chile
2 publications, 0.14%
|
Russia
|
Russia, 1, 0.07%
Russia
1 publication, 0.07%
|
Estonia
|
Estonia, 1, 0.07%
Estonia
1 publication, 0.07%
|
Egypt
|
Egypt, 1, 0.07%
Egypt
1 publication, 0.07%
|
Israel
|
Israel, 1, 0.07%
Israel
1 publication, 0.07%
|
Indonesia
|
Indonesia, 1, 0.07%
Indonesia
1 publication, 0.07%
|
Kenya
|
Kenya, 1, 0.07%
Kenya
1 publication, 0.07%
|
Lebanon
|
Lebanon, 1, 0.07%
Lebanon
1 publication, 0.07%
|
Luxembourg
|
Luxembourg, 1, 0.07%
Luxembourg
1 publication, 0.07%
|
Malaysia
|
Malaysia, 1, 0.07%
Malaysia
1 publication, 0.07%
|
Mexico
|
Mexico, 1, 0.07%
Mexico
1 publication, 0.07%
|
Namibia
|
Namibia, 1, 0.07%
Namibia
1 publication, 0.07%
|
Paraguay
|
Paraguay, 1, 0.07%
Paraguay
1 publication, 0.07%
|
Singapore
|
Singapore, 1, 0.07%
Singapore
1 publication, 0.07%
|
Show all (14 more) | |
50
100
150
200
250
300
350
|
Publishing countries in 5 years
5
10
15
20
25
30
|
|
USA
|
USA, 30, 21.9%
USA
30 publications, 21.9%
|
Germany
|
Germany, 27, 19.71%
Germany
27 publications, 19.71%
|
Denmark
|
Denmark, 24, 17.52%
Denmark
24 publications, 17.52%
|
United Kingdom
|
United Kingdom, 21, 15.33%
United Kingdom
21 publications, 15.33%
|
Norway
|
Norway, 16, 11.68%
Norway
16 publications, 11.68%
|
Sweden
|
Sweden, 16, 11.68%
Sweden
16 publications, 11.68%
|
Finland
|
Finland, 11, 8.03%
Finland
11 publications, 8.03%
|
Italy
|
Italy, 7, 5.11%
Italy
7 publications, 5.11%
|
Netherlands
|
Netherlands, 7, 5.11%
Netherlands
7 publications, 5.11%
|
Canada
|
Canada, 5, 3.65%
Canada
5 publications, 3.65%
|
France
|
France, 4, 2.92%
France
4 publications, 2.92%
|
China
|
China, 4, 2.92%
China
4 publications, 2.92%
|
Austria
|
Austria, 4, 2.92%
Austria
4 publications, 2.92%
|
Ireland
|
Ireland, 3, 2.19%
Ireland
3 publications, 2.19%
|
New Zealand
|
New Zealand, 3, 2.19%
New Zealand
3 publications, 2.19%
|
Switzerland
|
Switzerland, 3, 2.19%
Switzerland
3 publications, 2.19%
|
Iceland
|
Iceland, 2, 1.46%
Iceland
2 publications, 1.46%
|
Republic of Korea
|
Republic of Korea, 2, 1.46%
Republic of Korea
2 publications, 1.46%
|
Saudi Arabia
|
Saudi Arabia, 2, 1.46%
Saudi Arabia
2 publications, 1.46%
|
Estonia
|
Estonia, 1, 0.73%
Estonia
1 publication, 0.73%
|
Australia
|
Australia, 1, 0.73%
Australia
1 publication, 0.73%
|
Belgium
|
Belgium, 1, 0.73%
Belgium
1 publication, 0.73%
|
Brazil
|
Brazil, 1, 0.73%
Brazil
1 publication, 0.73%
|
Greece
|
Greece, 1, 0.73%
Greece
1 publication, 0.73%
|
Egypt
|
Egypt, 1, 0.73%
Egypt
1 publication, 0.73%
|
India
|
India, 1, 0.73%
India
1 publication, 0.73%
|
Kenya
|
Kenya, 1, 0.73%
Kenya
1 publication, 0.73%
|
Lebanon
|
Lebanon, 1, 0.73%
Lebanon
1 publication, 0.73%
|
Luxembourg
|
Luxembourg, 1, 0.73%
Luxembourg
1 publication, 0.73%
|
Namibia
|
Namibia, 1, 0.73%
Namibia
1 publication, 0.73%
|
Nigeria
|
Nigeria, 1, 0.73%
Nigeria
1 publication, 0.73%
|
Turkey
|
Turkey, 1, 0.73%
Turkey
1 publication, 0.73%
|
Chile
|
Chile, 1, 0.73%
Chile
1 publication, 0.73%
|
Japan
|
Japan, 1, 0.73%
Japan
1 publication, 0.73%
|
Show all (4 more) | |
5
10
15
20
25
30
|
1 profile journal article
Morch Anders
89 publications,
1 033 citations
h-index: 16